Exchange Announcement • 12 Nov 2025 20:23
Exchange Announcement • 12 Nov 2025 20:07
Exchange Announcement • 07 Nov 2025 05:31
Exchange Announcement • 06 Nov 2025 21:25
Exchange Announcement • 06 Nov 2025 21:22
Search or
𝛼SK
𝛼SKENTITY
Opus Genetics (IRD US)
Opus Genetics (IRD US)
1
Analysis
Health Care • United States
Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company. The Company focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs) and other retinal and refractive disorders. Opus Genetics serves customers worldwide.
morex